Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 96 of 100
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Features
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation’?
By
Laura Lorenzetti
March 5, 2015
Features
China cuts growth and a big pharma deal — 5 things to know today
By
Laura Lorenzetti
March 5, 2015
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By
Reuters
March 5, 2015
Tech
Is the future of pharma about making good drugs great?
By
Laura Lorenzetti
February 27, 2015
International
Sanofi taps Bayer’s Brandicourt for CEO job
By
Geoffrey Smith
February 20, 2015
Features
Candidate to lead FDA has close ties to big pharma
By
TIME
February 19, 2015
Leadership
Big Beef keeps getting bigger, thanks to growth drugs with unclear safety records
By
Deena Shanker
February 13, 2015
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By
Laura Lorenzetti
February 11, 2015
Leadership
Peter Thiel has never met a regulation he didn’t hate
By
Ben Geier
February 11, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Finance
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By
Jen Wieczner
February 6, 2015
Finance
Pfizer to acquire Hospira in a deal worth about $15 billion
By
Fortune Editors
February 5, 2015
Features
There’s a national shortage of saline solution. Yeah, we’re talking salt water. Huh?
By
Erika Fry
February 5, 2015
Features
In speed mode, FDA approves Pfizer’s big new drug early
By
Jen Wieczner
February 4, 2015
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting...
By
Eva Roytburg
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House post
By
Eleanor Pringle